A GLP-1 oral medication claims to cut the risk of cardiovascular complications, like heart attacks and strokes, by 14% for people with diabetes and heart or kidney disease, per CNBC.

Wegovy was also associated with a lower risk of hospitalization for heart failure, cardiovascular-related death, and ...

Jeremy Clarkson has updated fans on the challenging side effects of his attempts at weight loss as he reels from last year's ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...